Dupont Capital Management Corp Pacific Biosciences Of California, Inc. Transaction History

Dupont Capital Management Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$3.93 - $8.57 $77,845 - $169,754	19,808 New	19,808 $115,000
Q3 2021 Nov 03, 2021	SELL	$24.86 - $35.02 $437,063 - $615,686	-17,581 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$22.3 - $36.02 $392,056 - $633,267	17,581 New	17,581 $615,000
Q4 2020 Jan 28, 2021	SELL	$10.5 - $28.5 $1.01 Million - $2.74 Million	-96,079 Closed	0 $0
Q3 2020 Oct 29, 2020	SELL	$3.61 - $9.87 $73,023 - $199,650	-20,228 Reduced 17.39%	96,079 $948,000
Q2 2020 Jul 24, 2020	BUY	$2.65 - $4.03 $45,288 - $68,872	17,090 Added 17.22%	116,307 $401,000
Q1 2020 Apr 29, 2020	SELL	$2.36 - $5.26 $346,917 - $773,214	-146,999 Reduced 59.7%	99,217 $304,000
Q4 2019 Jan 27, 2020	BUY	$4.6 - $5.57 $351,256 - $425,325	76,360 Added 44.96%	246,216 $1.27 Million
Q3 2019 Oct 28, 2019	SELL	$4.99 - $6.16 $201,131 - $248,291	-40,307 Reduced 19.18%	169,856 $876,000
Q2 2019 Jul 30, 2019	BUY	$5.92 - $7.41 $744,499 - $931,881	125,760 Added 149.0%	210,163 $1.27 Million
Q1 2019 Apr 30, 2019	BUY	$6.8 - $7.4 $573,940 - $624,582	84,403 New	84,403 $610,000

255

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $450M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.